Surgical antibiotic prophylaxis administration practices.

IF 1.3 Q4 RESPIRATORY SYSTEM Public Health Action Pub Date : 2021-11-01 DOI:10.5588/pha.21.0027

S Shrestha, K Hann, K W Y Kyaw, P Koju, M Khogali

{"title":"Surgical antibiotic prophylaxis administration practices.","authors":"S Shrestha, K Hann, K W Y Kyaw, P Koju, M Khogali","doi":"10.5588/pha.21.0027","DOIUrl":null,"url":null,"abstract":"Setting: A referral hospital in Kavre, Nepal.Objectives: To assess 1) compliance with National Antibiotic Treatment Guidelines (NATG), specifically, whether the administration of surgical antibiotic prophylaxis (SAP) (initial dosing and redosing) was in compliance with NATG for patients who were and were not eligible, and 2) development of surgical site infections (SSIs) among patients who underwent surgery in the Department of General Surgery (July-December 2019).Design: This was a retrospective cohort analysis.Results: The analysis included 846 patients, of which 717 (85%) patients were eligible for SAP and 129 (15%) were ineligible. Of those eligible, 708 (99%) received the initial dose; while 65 (50%) of the ineligible did not receive any dose. Of those who received the initial dose, 164 (23%) were eligible for redosing. Of these, only 23 (14%) received at least one redosing and 141 (86%) did not receive it. Overall compliance with NATG was achieved in 75% (632/846) of patients. SSIs occurred in 23 (3%) patients, 8 (35%) of whom did not have SAP administered according to NATG.Conclusion: A relatively high overall compliance with NATG for SAP administration was reported. Recommendations were made to improve compliance among those who were ineligible for SAP and those who were eligible for redosing.","PeriodicalId":46239,"journal":{"name":"Public Health Action","volume":"11 Suppl 1","pages":"18-23"},"PeriodicalIF":1.3000,"publicationDate":"2021-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8575384/pdf/","citationCount":"2","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Public Health Action","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.5588/pha.21.0027","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"RESPIRATORY SYSTEM","Score":null,"Total":0}

引用次数: 2

Abstract

Setting: A referral hospital in Kavre, Nepal.

Objectives: To assess 1) compliance with National Antibiotic Treatment Guidelines (NATG), specifically, whether the administration of surgical antibiotic prophylaxis (SAP) (initial dosing and redosing) was in compliance with NATG for patients who were and were not eligible, and 2) development of surgical site infections (SSIs) among patients who underwent surgery in the Department of General Surgery (July-December 2019).

Design: This was a retrospective cohort analysis.

Results: The analysis included 846 patients, of which 717 (85%) patients were eligible for SAP and 129 (15%) were ineligible. Of those eligible, 708 (99%) received the initial dose; while 65 (50%) of the ineligible did not receive any dose. Of those who received the initial dose, 164 (23%) were eligible for redosing. Of these, only 23 (14%) received at least one redosing and 141 (86%) did not receive it. Overall compliance with NATG was achieved in 75% (632/846) of patients. SSIs occurred in 23 (3%) patients, 8 (35%) of whom did not have SAP administered according to NATG.

Conclusion: A relatively high overall compliance with NATG for SAP administration was reported. Recommendations were made to improve compliance among those who were ineligible for SAP and those who were eligible for redosing.

Abstract Image

查看原文

微信好友朋友圈 QQ好友复制链接

本刊更多论文

外科抗生素预防管理实践。

背景：尼泊尔Kavre的一家转诊医院。目的：评估1）符合国家抗生素治疗指南（NATG）的情况，特别是符合和不符合条件的患者的外科抗生素预防（SAP）（首次给药和重新给药）是否符合NATG，和2）在普通外科接受手术的患者中手术部位感染（SSIs）的发展（2019年7月至12月）。设计：这是一项回顾性队列分析。结果：分析包括846名患者，其中717名（85%）患者符合SAP条件，129名（15%）患者不符合SAP条件。在符合条件的人群中，708人（99%）接受了初始剂量；而65名（50%）不合格者没有接受任何剂量。在接受初始剂量的患者中，有164人（23%）有资格再次服用。在这些患者中，只有23人（14%）接受了至少一次重做，141人（86%）没有接受。75%（632/846）的患者达到了NATG的总体依从性。SSIs发生在23名（3%）患者中，其中8名（35%）患者没有按照NATG给药SAP。结论：据报道，SAP给药对NATG的总体依从性相对较高。提出了一些建议，以提高那些不符合SAP条件的人和那些有资格重做的人的合规性。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文去求助

来源期刊

Public Health Action RESPIRATORY SYSTEM-

自引率

0.00%

发文量

期刊介绍： Launched on 1 May 2011, Public Health Action (PHA) is an official publication of the International Union Against Tuberculosis and Lung Disease (The Union). It is an open access, online journal available world-wide to physicians, health workers, researchers, professors, students and decision-makers, including public health centres, medical, university and pharmaceutical libraries, hospitals, clinics, foundations and institutions. PHA is a peer-reviewed scholarly journal that actively encourages, communicates and reports new knowledge, dialogue and controversy in health systems and services for people in vulnerable and resource-limited communities — all topics that reflect the mission of The Union, Health solutions for the poor.